| |
|
| |
 |
| |
| Asia / America / Europe |
| |
 |
|
D A Prasanna
Chairman and Managing Director
As a founder, he has mapped the vision and strategy for the organization. He has experience in leveraging Asian competitiveness building successful global business in medical technology for GE and software for Wipro. As Exec Chairman of the Manipal Group, his focus was on developing a research thrust for the Group. Considered a thought leader in Health care and Life Sciences, he has worked in global leadership positions in GE and was Vice Chairman of Wipro. He serves on the board of various Pharma companies and Research institutes.
Prasanna is acknowledged in the healthcare sector as the pioneer in creating a market for high tech. medical equipment and delivering clinical excellence at low patient fees in Asian Hospitals, through innovative strategies. As the startup CEO of GE Medical in India, he also developed a $330 m Global Business in healthcare for GE Medical Systems (GEMS) by leveraging India's competitiveness taking the company from no 5 to No 1. He has also been a founding member of Wipro's team that initiated the company's entry into IT and was Vice Chairman of Wipro Ltd.
He is an independent Director of Take Solutions Ltd. He serves on the Governing Council of Center for Policy Research, India's leading Think Tank and of T A Pai Management Institute, a reputed Business School. He is a Trustee on Shriram Ownership Trust, which shapes the strategy of Shriram group of companies. He has served as Chairman of GEBEL, GEMS IT Ltd and GE X-Ray(South Asia) and Director of GE Yokogawa Medical Systems Ltd, Japan and GE Samsung Ltd, Korea, Wipro GE Medical Systems Ltd, India and Shasun Chemical & Drugs Ltd India. He brings rich experience in pharma and healthcare.
Mr. Prasanna is an alumnus of IIM Ahmedabad & GE Global Business Leadership Program at Crotonville. |
| |
|
|
 |
|
Balaji Durai Iyengar
Country Manager & CEO - India
Balaji Durai Iyengar as Country Manager & Chief Executive Officer is accountable for managing and accelerating the growth of India business.
Balaji joined us as one of the founding members in 2005 January. He has played a key role in evolving the strategy, monitoring performance and raising resources. As a key member of the M&A team, he was instrumental in the globalization initiatives in the Company & played a vital role in expansion to Europe the company’s operations. During his tenure he has established great credibility with private equity funds & key investors in life sciences domain, whoare thought leaders in the Pharma industry.
He has worked closely with the business leaders and the Board to contribute to our journey so far. He has served on the Board of Ecron Acunova GmbH and brings the insight of both Europe and India business to build synergy. He joined Manipal group and served in distance education, healthcare BPO, clinical process outsourcing services in finance function. He has the distinction of working in four start-up companies and contributing to their successful growth.
He is a member of the Finance council of the prestigious CII(Confederation of Indian Industry), Karnataka Chapter. He is a member of the Institute of Chartered Accountants of India with nearly 15 years of industry experience. |
| |
|
|
 |
|
Kohkan Shamsi, MD & PhD
CEO Ecron Acunova US
Kohkan Shamsi MD, PhD is a radiologist and has more than 20 years of pharmaceutical, regulatory, clinical and academic experience.
Dr. Shamsi started his career as a Radiologist with Ministry of Health, Saudi Arabia. Then he joined the department of radiology in Antwerp University Hospital, Belgium where he completed his PhD. He moved to Berlin and worked as Research Physician in Diagnostic Imaging at Schering AG, Berlin, Germany. After working for about 5 years in Germany he was transferred to Berlex Inc. New Jersey, USA (a subsidiary of Schering AG) where he has worked for about 8 years as Senior Associate Director, Clinical Development and rose to the position of Head, Medical Development of Diagnostic Imaging & Radio pharmaceuticals & Head of Global Medical Imaging.
Dr. Shamsi has conceptualized, coordinated, and executed over 25 multi-center, international clinical trials (phase I - phase III) to develop new MRI contrast agents for oncology imaging, CNS, Magnetic Resonance Angiography and cardiac imaging. These trials were performed in Europe, the USA, South America and Australia and India. He was one of the first at Schering AG to leverage emerging markets like Latin America and India in clinical trials.
Dr. Shamsi has submitted many NDAs in Europe, USA and Japan with successful outcomes and interacts with regulatory agencies for IND, PMA, pre NDA and other regulatory meetings.
Dr Shamsi has published extensively including book, book chapter and more than 90 papers and abstracts in indexed journals. He regularly participate in various scientific forums, meetings, initiatives for image standardization, image evaluations, and image management for drug development and lectures in global meetings and conferences.
Since 2006, he has been with Ecron Acunova in leadership positions and continues to contribute to its phenomenal growth. |
| |
|
|
 |
|
Antal K Hajos, PhD
CEO Ecron Acunova Europe
Dr Hajos focusses on leveraging and streamlining the opportunities of the company's Indian and European capabilities via client development, integration of system and processes, and expanding the service level as appropriate. Based out of the company's European HQ in Frankfurt, Germany, Dr Hajos’ experience and network of relationships in the Pharma & CRO domain will be helpful to the Ecron Acunova's Indian and European team in tapping this potential market.
With over 15 years experience, Dr Hajos brings extensive experience in clinical development and medical writing. He has developed his expertise with companies like Merckle GmbH (a group company of Ratiopharm GmbH) and Altana Pharma AG. Prior to joining Ecron Acunova, he was working as Managing Director and Chair of the Board with Nycomed Pharma's Indian R&D center based at Mumbai. He was also a member of Nycomed's global R&D leadership team responsible for R&D strategies & operations worldwide. Dr Hajos was previously responsible for managing Altana's global clinical operations across 22 countries
worldwide out of the German Headquarters. Dr Hajos has also worked with Omnicare Clinical Research GmbH, Germany as Program Director & Head - Medical Writing and Drug Development Design where he was responsible for medical, regulatory and strategic consulting on global clinical programs.
Dr Hajos is a member of the European Medical Writer's Association, ICRS, and founding member of the All India Medical Writer's Association to name a few. He has over 10 publications in many international journals and has done numerous abstract writing and had been the presenter for many invited conferences to his credit.
Dr Hajos has completed his Ph D in Biochemistry from Louisiana State University, USA, where he was awarded the Robert Scott Alan Outstanding dissertation award. He has also completed the Asian Executive Management Program from INSEAD, Singapore. |
|
|
|
